OraLife® Gel is used to treat oral mucositis, stomatitis and red, painful, swollen and/or dry mucous membranes of the mouth and throat caused by radiotherapy or chemotherapy.
Remedy for inflammation of the mucous membranes in the mouth and throat and dry mouth in cancer therapy
The mucous membranes of the mouth and throat can be damaged by cancer therapy (chemotherapy or radiotherapy). These defects often only occur during the course of cancer treatment. They can be painful and severely impair quality of life. Some of the consequences are inflammation of the oral mucosa, dry mouth, burning, aphthae and pain.
OraLife® Gel can provide relief. The soothing and anti-inflammatory properties of OraLife® Gel result from the ingredients of F.A.G.®. These can minimise the inflammatory reactions of the oral and pharyngeal mucosa in cancer therapy.
Starting treatment with OraLife® Gel at an early stage can thus reduce the side effects of cancer therapy on the oral and pharyngeal mucosa. OraLife® Gelhas a pleasant, subtle flavour and can be swallowed without hesitation.
- cortisone-free
- hormone-free
Note: OraLife Gel can also be used with a tracheostomy tube
Dosage form
gel
Application
For damage to the oral mucosa caused by radiotherapy, chemotherapy or other cancer therapies. OraLife® Gel should be applied as required or 3 to 4 times a day.
Ingredients
Composition: water, glycerine, ethylhexyl stearate, Fatty Acid Group (F.A.G.®, oleic acid, α-linolenic acid, linoleic acid, myristic acid, arachidic acid, palmitic acid, stearic acid), N-(2-hydroxyethyl)hexadecanamide, panthenol, triethanolamine, hyaluronic acid, Perfume, polyacrylic acid, acrylate/C10-30 alkyl acrylate crosspolymer, sodium methylparaben, chlorhexidine, ethyl linoleate, olea europaea, disodium EDTA, tocopherol, palmitic acid ascorbyl ester.
